|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Deferred income taxes, net | |||||
| SBA recourse benefit | |||||
| Tax credit investments recovery | |||||
| Provision for credit losses | |||||
| Depreciation, amortization and accretion, net | |||||
| Share-based compensation | |||||
| Net loss on disposal of fixed assets | |||||
| Net loss on sale of tax credit investments | |||||
| Net losses on sales and impairments of tax credit investments | |||||
| Amortization of tax credit investments | |||||
| Bank-owned life insurance policy income | |||||
| Origination of loans for sale | |||||
| Sale of loans originated for sale | |||||
| Gain on sale of loans originated for sale | |||||
| Net loss on repossessed assets | |||||
| Return on investment in limited partnerships | |||||
| Excess tax benefit from share-based compensation | |||||
| Net payments on operating lease liabilities | |||||
| Net decrease (increase) in accrued interest receivable and other assets | |||||
| Net (decrease) increase in accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Proceeds from maturities, redemptions, and paydowns of available-for-sale securities | |||||
| Proceeds from maturities, redemptions, and paydowns of held-to-maturity securities | |||||
| Proceeds from sale of available-for-sale securities | |||||
| Purchases of available-for-sale securities | |||||
| Proceeds from sale of repossessed assets | |||||
| Net increase in loans and leases | |||||
| Investments in limited partnerships | |||||
| Returns of investments in limited partnerships | |||||
| Investment in tax credit investments | |||||
| Distribution from tax credit investments | |||||
| Proceeds from sale of tax credit | |||||
| Investment in Federal Home Loan Bank stock | |||||
| Proceeds from the sale of Federal Home Loan Bank stock | |||||
| Proceeds from sale of leasehold improvements and equipment, net | |||||
| Purchases of leasehold improvements and equipment, net | |||||
| Proceeds from sale of leasehold improvements and equipment | |||||
| Premium payment on bank owned life insurance policies | |||||
| Purchases of bank owned life insurance policies | |||||
| Proceeds from bank owned life insurance claim | |||||
| Proceeds from redemption of Trust II stock | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net increase in deposits | |||||
| Repayment of Federal Home Loan Bank advances | |||||
| Proceeds from Federal Home Loan Bank advances | |||||
| Repayment of subordinated notes and debentures | |||||
| Repayment of junior subordinated debt | |||||
| Proceeds from issuance of subordinated notes and debentures | |||||
| Net increase (decrease) in long-term borrowed funds | |||||
| Cash dividends paid | |||||
| Preferred stock dividends paid | |||||
| Proceeds from issuance of common stock under ESPP | |||||
| Proceeds from issuance of preferred stock | |||||
| Purchase of treasury stock | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
| Supplementary cash flow information | |||||
| Cash paid during the period for: | |||||
| Interest paid on deposits and borrowings | |||||
| Net income taxes paid | |||||
| Transfer of loans to foreclosed properties | |||||
| Non-cash investing and financing activities: | |||||
| Transfer of repossessed assets to (from) loans | |||||
| Lease liability in exchange for right-of-use-asset | |||||
Loading...